Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical retinoic acid 0.05% versus 5% retinoic acid peel on photodamaged forearm skin
RBR-2vmk27Completed
- Sponsor
- Federal University of São Paulo
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tretinoin in actinic keratosis (AK), photoaging, Hyperpigmentation and 3 more (2 arms), sponsored by Federal University of São Paulo. Primary endpoints: Histopathologic evaluation and Immunohistochemical evaluation. Started Jun 2013; status: completed.
02
Drugs
tretinoin
03
Conditions
actinic keratosis (AK)photoagingHyperpigmentationcutis laxaleukoderma
Beyond the preview
Go deeper on RBR-2vmk27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2vmk27.